The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Expression profiling of metalloproteinases and their inhibitors in cartilage
Open accessAbstract
Objective: To profile the expression of all known members of the matrix metalloproteinase (MMP), ADAMTS, and tissue inhibitor of metalloproteinases (TIMP) gene families in normal cartilage and cartilage from patients with osteoarthritis (OA). Methods: Human cartilage was obtained from femoral heads at joint replacement for OA or following fracture to the femoral neck. Total RNA was purified, and gene expression was assayed using quantitative real‐time polymerase chain reaction. Results: Several members of the above gene families were regulated in OA. Genes that showed increased expression in OA were MMP13, MMP28, and ADAMTS16 (all at P < 0.001), MMP9, MMP16, ADAMTS2, and ADAMTS14 (all at P < 0.01), and MMP2, TIMP3, and ADAMTS12 (all at P < 0.05). Genes with decreased expression in OA were MMP1, MMP3, and ADAMTS1 (all at P < 0.001), MMP10, TIMP1, and ADAMTS9 (all at P < 0.01), and TIMP4, ADAMTS5, and ADAMTS15 (all at P < 0.05). Correlation analysis revealed that groups of genes across the gene families were coexpressed in cartilage. Conclusion: This is the first comprehensive expression profile of all known MMP, ADAMTS, and TIMP genes in cartilage. Elucidation of patterns of expression provides a foundation with which to understand mechanisms of gene regulation in OA and potentially to refine the specificity of antiproteolytic therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holmbeck, K., Bianco, P., Caterina, J., Yamada, S., Kromer, M., Kuznetsov, S. A., Mankani, M., Gehron Robey, P., Poole, A. R., Pidoux, I., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80064-1 · Cited by 1,298
Proteoglycans: many forms and many functions
Hardingham, T. E., & Fosang, A. J. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.3.1740236 · Cited by 1,195
Metalloproteinase inhibitors: biological actions and therapeutic opportunities
Baker, A. H., Edwards, D. R., & Murphy, G. (2002) · Journal of Cell Science · doi:10.1242/jcs.00063 · Cited by 1,179
Self-citationOhuchi, E., Imai, K., Fujii, Y., Sato, H., Seiki, M., & Okada, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2446 · Cited by 938
Biochemical Characterization of Human Collagenase-3
Knäuper, V., López-Otin, C., Smith, B., Knight, G., & Murphy, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1544 · Cited by 881
Tetlow, L. C., Adlam, D. J., & Woolley, D. E. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200103)44:3<585::aid-anr107>3.0.co;2-c · Cited by 736
Purification and Cloning of Aggrecanase-1: A Member of the ADAMTS Family of Proteins
Tortorella, M. D., Burn, T. C., Pratta, M. A., Abbaszade, I., Hollis, J. M., Liu, R., Rosenfeld, S. A., Copeland, R. A., Decicco, C. P., Wynn, R., et al. (1999) · Science · doi:10.1126/science.284.5420.1664 · Cited by 686
Zhou, Z., Apte, S. S., Soininen, R., Cao, R., Baaklini, G. Y., Rauser, R. W., Wang, J., Cao, Y., & Tryggvason, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.060037197 · Cited by 666
Sekiya, I., Vuoristo, J. T., Larson, B. L., & Prockop, D. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052716199 · Cited by 648
TIMP-3 Is a Potent Inhibitor of Aggrecanase 1 (ADAM-TS4) and Aggrecanase 2 (ADAM-TS5)
Kashiwagi, M., Tortorella, M., Nagase, H., & Brew, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000848200 · Cited by 509
Cited by
Structure and function of matrix metalloproteinases and TIMPs
NAGASE, H., VISSE, R., & MURPHY, G. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.12.002 · Cited by 3,409
Biochemical and Biological Attributes of Matrix Metalloproteinases
Cui, N., Hu, M., & Khalil, R. A. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.02.005 · Cited by 1,359
ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro
Stanton, H., Rogerson, F. M., East, C. J., Golub, S. B., Lawlor, K. E., Meeker, C. T., Little, C. B., Last, K., Farmer, P. J., Campbell, I. K., et al. (2005) · Nature · doi:10.1038/nature03417 · Cited by 915
Pelttari, K., Winter, A., Steck, E., Goetzke, K., Hennig, T., Ochs, B. G., Aigner, T., & Richter, W. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22136 · Cited by 809
PORTER, S., CLARK, I. M., KEVORKIAN, L., & EDWARDS, D. R. (2005) · Biochemical Journal · doi:10.1042/bj20040424 · Cited by 779
Self-citationCartilage homeostasis in health and rheumatic diseases
Goldring, M. B., & Marcu, K. B. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2592 · Cited by 762
Progress in matrix metalloproteinase research
MURPHY, G., & NAGASE, H. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2008.05.002 · Cited by 759
Little, C. B., Barai, A., Burkhardt, D., Smith, S. M., Fosang, A. J., Werb, Z., Shah, M., & Thompson, E. W. (2009) · Arthritis & Rheumatism · doi:10.1002/art.25002 · Cited by 642
Osteoarthritis — an untreatable disease?
Wieland, H. A., Michaelis, M., Kirschbaum, B. J., & Rudolphi, K. A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1693 · Cited by 585
Proteases involved in cartilage matrix degradation in osteoarthritis
Troeberg, L., & Nagase, H. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.06.020 · Cited by 579
Zymographic Techniques for the Analysis of Matrix Metalloproteinases and their Inhibitors
Snoek-van Beurden, P. A. M., & Von den Hoff, J. W. (2005) · BioTechniques · doi:10.2144/05381rv01 · Cited by 523
Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis
Hu, Q., & Ecker, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041742 · Cited by 475
ADAMTS-4 and ADAMTS-5: Key enzymes in osteoarthritis
Verma, P., & Dalal, K. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23298 · Cited by 412
Csaki, C., Mobasheri, A., & Shakibaei, M. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2850 · Cited by 318
Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?
Murphy, G., & Nagase, H. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0727 · Cited by 316
ADAMTS and ADAM metalloproteinases in osteoarthritis – looking beyond the ‘usual suspects’
Yang, C.-Y., Chanalaris, A., & Troeberg, L. (2017) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2017.02.791 · Cited by 291
Genome-wide expression profiling reveals new candidate genes associated with osteoarthritis
Karlsson, C., Dehne, T., Lindahl, A., Brittberg, M., Pruss, A., Sittinger, M., & Ringe, J. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2009.12.002 · Cited by 259
Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease
Scott, J. L., Gabrielides, C., Davidson, R. K., Swingler, T. E., Clark, I. M., Wallis, G. A., Boot-Handford, R. P., Kirkwood, T. B. L., Talyor, R. W., & Young, D. A. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.119966 · Cited by 255
Self-citationHao, H. Q., Zhang, J. F., He, Q. Q., & Wang, Z. (2019) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2018.10.009 · Cited by 118
Shared gene expression profiles in developing heart valves and osteoblast progenitor cells
Chakraborty, S., Cheek, J., Sakthivel, B., Aronow, B. J., & Yutzey, K. E. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.90212.2008 · Cited by 75
Bespalova, I. N., Angelo, G. W., Ritter, B. P., Hunter, J., Reyes-Rabanillo, M. L., Siever, L. J., & Silverman, J. M. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8169-y · Cited by 14
Metadata
- Authors
- Kevorkian, L., Young, D. A., Darrah, C., Donell, S. T., Shepstone, L., Porter, S., Brockbank, S. M. V., Edwards, D. R., Parker, A. E., & Clark, I. M.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2004-01
- Volume
- 50
- Issue
- 1
- Pages
- 131-141
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2015354603
- Cited by
- 404
- References
- 45
- FWCI
- 9.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.